IndraLab

Statements


| 4

reach
"Lithium attenuates IFN-beta production and antiviral response via inhibition of TANK binding kinase 1 kinase activity."

reach
"Lithium has been shown to inhibit TBK1 kinase activity in a GSK3β-independent manner, attenuating TLR3/4 and RIG-I immune pathways that mediate IFNβ production and antiviral responses.39 Thus, lithium was assumed to have therapeutic potential to intervene in autoimmune diseases caused by uncontrolled IFN-β production."

reach
"In vitro kinase assay demonstrates that lithium suppresses TANK binding kinase 1 kinase activity."

reach
"Recent report shows that lithium could decrease TANK-Binding Kinase 1 Kinase (TBK-1) activity by competing with Mg 2+ and inhibit the phosphorylation of TBK-1 substrates, which attenuates the IFN-β pr[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"